Point72 Hong Kong’s Pfizer PFE Stock Holding History

Point72 Hong Kong’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-19,800	Closed	-$866K	–	1263
2022 Q3	$866K	Sell	19,800 -126,700	-86%	-$6.16M	0.03%	586
2022 Q2	$7.68M	Sell	146,500 -63,200	-30%	-$3.22M	0.28%	72
2022 Q1	$10.9M	Buy	209,700 +69,200	+49%	+$3.59M	0.37%	39
2021 Q4	$8.3M	Sell	140,500 -96,000	-41%	-$4.76M	0.29%	48
2021 Q3	$10.2M	Buy	236,500 +149,500	+172%	+$6.62M	0.33%	31
2021 Q2	$3.41M	Buy	87,000 +26,800	+45%	+$1.04M	0.11%	224
2021 Q1	$2.18M	Sell	60,200 -38,700	-39%	-$1.37M	0.07%	368
2020 Q4	$3.64M	Buy	+98,900	New	+$3.63M	0.16%	131

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Point72 Hong Kong's PFE Position: Q2 2024 in Review

Point72 Hong Kong sold out of Pfizer (PFE) in Q2 2024, closing a stake of 1,859 shares — an estimated $51.6K sold.

Point72 Hong Kong first reported a position in PFE in Q1 2015 and held it in 19 quarters. The position peaked at $4.75M in Q1 2020. 2,874 funds tracked by Wall St. Rank hold PFE as of Q2 2024.

Point72 Hong Kong reported no remaining Pfizer position as of Q2 2024 after selling out during the quarter.
Point72 Hong Kong sold 1,859 Pfizer shares in Q2 2024, an estimated $51.6K.
Point72 Hong Kong first reported a position in Pfizer in Q1 2015 and held it in 19 quarters.
Point72 Hong Kong's Pfizer position peaked at $4.75M in Q1 2020.
2,874 funds tracked by Wall St. Rank held Pfizer as of Q2 2024.

Based on Point72 Hong Kong's 13F filing for Q2 2024, filed 14 Aug 2024.